Articles

October 3, 2024 Better Together: Collaborating for Rare Disease Care, Pharmacy Innovation Network One critical way to address this goal is through strategic collaborations such as the Pharmacy Innovation Network (PIN), Read More ›
September 26, 2024 Confronting the World’s Leading Killer with a New Therapeutic Approach For Xicang Guo and Jiaming Zhang, one particular condition remains stubbornly beyond their control – hypertension, also known as high blood pressure. Read More ›
September 12, 2024 RNAi Therapeutics, from Possibility to Patients The story of an innovative approach to silencing disease that’s improving lives and changing expectations for medicine. Read More ›
September 10, 2024 Alnylam Named a Best Workplace for Innovators for the 4th Year in a Row by Fast Company Alnylam has been named a Fast Company Best Workplace for Innovators for 2024, our 4th year in a row on the list. Read More ›
August 15, 2024 Alnylam Named a Humankind 100 Company for the 3rd Year in a Row Alnylam has been named to the HumanKind 100 list for the 2nd year in a row and we’re pleased to have moved up in the rankings from #97 in 2022 to #76 in 2023. Read More ›
May 7, 2024 Alnylam Publishes 2023 Corporate Responsibility Report Alnylam's 2023 Corporate Responsibility Report details our corporate responsibility and ESG efforts and progress. Read More ›
April 26, 2024 Better Together: Alnylam and Organized Customer Health Systems Want to Improve Access and ... Alnylam's Head of Strategic Accounts discusses the rise of the Integrated Delivery Network and manufacturer relationship Read More ›
April 25, 2024 Our Commitment to Patients Means Never Stop Evolving - Our Patient Access Philosophy Tolga Tanguler, Alnylam's Chief Commercial Officer discusses Alnylam's Patient Access Philosophy and approach to access Read More ›
April 16, 2024 Alnylam Ranked #3 on LinkedIn's List of Top Midsize Companies for 2024 Alnylam is proud to be included on LinkedIn's Top Companies list for 2024. Read More ›

You are now leaving Alnylam.com

The following content may not be associated with Alnylam Pharmaceuticals.

Links to all outside sites are provided as a reference for our visitors.

Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.

Proceed to Site